Objectives: We aimed to assess the variation in patient body weight over time according to the treatment
outcome among multidrug-resistant tuberculosis (MDR-TB) cases.
Methods: This was a retrospective cohort study. The data of patients commencing MDR-TB therapy were
analyzed. Data were collected from different public TB treatment facilities located in peri-urban areas to
the south of Lima, Peru. The outcome was patient body weight (kilograms) from treatment
commencement, measured monthly. A random effects model was fitted using robust standard errors
to calculate 95% confidence intervals.
Results: Of a total of 1242 TB cases, 243 (19.6%) were MDR-TB. Only 201 cases were included in the
analysis; 127 (63.2%) were males and the mean patient age was 33.6 (standard deviation 16.2) years.
Weight changes over time among the patients who were cured differed from changes in those who died
during therapy (p < 0.001). Weight curve divergence was important at the end of the third, fourth, and
fifth treatment months: on average, the weight difference was 2.18 kg (p < 0.001), 3.27 kg (p = 0.007),
and 3.58 kg (p = 0.03), respectively, when cured patients were compared to those who died.
Conclusions: Our results show that weight variation during treatment can be a useful surrogate for the
treatment outcome, specifically death during therapy. MDR-TB patients with weight loss should be
followed more closely, as they are at greater risk of death.
Authors: Chung Delgado, Kocfa; Revilla Montag, Alejandro; Guillén Bravo, Sonia; Bernabe Ortiz, Antonio
Source: International Journal of Infectious Diseases
URL: http://hdl.handle.net/10757/326115
No hay comentarios:
Publicar un comentario